Table 4.
ERIC Cluster and Strategy | Cumulative Endorsement Percentage | Level 1 and 2 Endorsed CFIR Barriers | Go-Zone Quadrant |
---|---|---|---|
Develop Stakeholder Interrelationships | |||
Identify and prepare champions | 418% |
Evidence strength & quality Relative advantage Adaptability Complexity Structural characteristics Compatibility Knowledge & beliefs Opinion leaders Key stakeholders Patients/consumers |
I |
Build a coalition | 286% |
Cosmopolitanism Structural characteristics Compatibility Opinion leaders Key stakeholders |
I |
Conduct local consensus discussions | 352% |
Evidence strength & quality Relative advantage Adaptability Patient needs & resources Compatibility Relative priority Opinion leaders Key stakeholders |
I |
Inform local opinion leaders | 259% |
Evidence strength & quality Relative advantage Knowledge & beliefs Opinion leaders Key stakeholders |
I |
Capture and share local knowledge | 264% |
Evidence strength & quality Adaptability Complexity Cosmopolitanism Structural characteristics Available resources Knowledge & beliefs |
I |
Identify early adopters | 215% |
Evidence strength & quality Adaptability Complexity Structural characteristics Knowledge & beliefs Opinion leaders |
I |
Use advisory boards and workgroups | 182% |
Patient needs & resources Cosmopolitanism Key stakeholders Patients/consumers |
I |
Promote network weaving | 148% |
Cosmopolitanism Structural characteristics |
III |
Visit other sites | 145% |
Relative advantage Cosmopolitanism |
II |
Involve executive boards | 122% |
Cosmopolitanism Key stakeholders |
II |
Develop academic partnerships | 116% |
Evidence strength & quality Cosmopolitanism |
II |
Recruit, designate, and train for leadership | 109% | Opinion leaders | IV |
Model and simulate change | 108% | Complexity | II |
Organize clinician implementation team meetings | 96% | Complexity | I |
Use an implementation advisor | 95% | None | I |
Obtain formal commitments | 75% | None | IV |
Use Evaluative and Iterative Strategies | |||
Assess for readiness and identify barriers and facilitators | 351% |
Relative advantage Adaptability Complexity Patient needs & resources Structural characteristics Compatibility Relative priority Knowledge & beliefs Key stakeholders |
I |
Conduct local needs assessment | 293% |
Relative advantage Adaptability Patient needs & resources Compatibility Relative priority Knowledge & beliefs Key stakeholders |
I |
Conduct cyclical small tests of change | 210% |
Relative advantage Adaptability Complexity Structural characteristics Compatibility |
I |
Obtain and use patients/consumers and family feedback | 187% |
Patient needs & resources Patients/consumers |
I |
Develop a formal implementation blueprint | 124% | Complexity | I |
Stage implementation scale up | 111% |
Complexity Available resources |
I |
Purposefully re-examine the implementation | 101% | Compatibility | I |
Audit and provide feedback | 86% | None | I |
Develop and implement tools for quality monitoring | 53% | None | I |
Develop and organize quality monitoring systems | 45% | None | I |
Train and Educate Stakeholders | |||
Conduct educational meetings | 263% |
Evidence strength & quality Relative advantage Knowledge & beliefs Opinion leaders Key stakeholders |
I |
Create a learning collaborative | 219% |
Adaptability Complexity Cosmopolitanism Key stakeholders |
II |
Conduct educational outreach visits | 169% |
Evidence strength & quality Cosmopolitanism Knowledge & beliefs |
II |
Develop educational materials | 177% |
Evidence strength & quality Knowledge & beliefs Patients/consumers |
I |
Distribute educational materials | 110% | Evidence strength & quality | I |
Provide ongoing consultation | 92% | Complexity | I |
Conduct ongoing training | 75% | Complexity | I |
Work with educational institutions | 59% | None | II |
Use train-the-trainer strategies | 56% | None | I |
Shadow other experts | 44% | None | II |
Make training dynamic | 40% | None | I |
Adapt and Tailor to Context | |||
Promote adaptability | 285% |
Relative advantage Adaptability Complexity Structural characteristics Compatibility |
I |
Tailor strategies | 223% |
Adaptability Complexity Compatibility |
I |
Use data experts | 46% | None | III |
Provide Interactive Assistance | |||
Facilitation | 173% |
Adaptability Complexity Compatibility Knowledge & beliefs |
I |
Provide local technical assistance | 72% | None | IV |
Centralize technical assistance | 36% | None | III |
Support Clinicians | |||
Develop resource sharing agreements | 80% |
Cosmopolitanism Available resources |
III |
Facilitate relay of clinical data to providers | 65% | None | I |
Revise professional roles | 48% | None | III |
Create new clinical teams | 40% | None | III |
Engage Consumers | |||
Involve patients/consumers and family members | 236% |
Patient needs & resources Opinion leaders Patients/consumers |
I |
Prepare patients/consumers to be active participants | 118% |
Patient needs & resources Patients/consumers |
IV |
Increase demand | 115% |
Relative advantage Relative priority Available resources |
II |
Intervene with patients/consumers to enhance uptake & adherence | 106% |
Patient needs & resources Patients/consumers |
IV |
Use mass media | 90% | Patients/consumers | III |
Use Financial Strategies | |||
Alter incentive/allowance structures | 179% |
Relative advantage Relative priority |
III |
Access new funding | 134% | Available resources | IV |
Fund and contract for clinical innovation | 103% | Available resources | IV |
Alter patient/consumer fees | 44% |
Available resources Patients/consumers |
III |
Place innovation on fee for service lists/formularies | 38% | None | IV |
Make billing easier | 32% | Available resources | III |
Change Infrastructure | |||
Change physical structure and equipment | 97% |
Structural characteristics Available resources |
III |
Mandate change | 65% | Relative priority | III |
Create or change credentialing and/or licensure standards | 41% | None | III |
Change service sites | 38% | None | III |
Change record systems | 29% | None | III |
CFIR Consolidated Framework for Implementation Research, ERIC Expert Recommendations for Implementing Change; Cumulative Endorsement Percentage, collective percentages of all endorsement across all identified CFIR barriers; Go-zone quadrant I, high importance and feasibility; Go-zone quadrant II, low importance and high feasibility; Go-zone quadrant III, low importance and feasibility; Go-zone quadrant IV, high importance and low feasibility